An Exploratory Study of Sintilimab Combined with CAPOX for Initially Unresectable High-Risk Locally Advanced Rectal Cancer Patients with Proficient Mismatch Repair and/or Microsatellite Stable Status

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: ab99a642b09624594dd03dfb5e93d40bdf23756c
First added on: Sep 12, 2026